Vicki Osborne

576 total citations
34 papers, 344 citations indexed

About

Vicki Osborne is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Vicki Osborne has authored 34 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 10 papers in Epidemiology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Vicki Osborne's work include Opioid Use Disorder Treatment (10 papers), Substance Abuse Treatment and Outcomes (6 papers) and Prenatal Substance Exposure Effects (5 papers). Vicki Osborne is often cited by papers focused on Opioid Use Disorder Treatment (10 papers), Substance Abuse Treatment and Outcomes (6 papers) and Prenatal Substance Exposure Effects (5 papers). Vicki Osborne collaborates with scholars based in United Kingdom, United States and Netherlands. Vicki Osborne's co-authors include Saad Shakir, Linda B. Cottler, Catherine W. Striley, Deborah Layton, Mirsada Serdarevic, Debabrata Roy, Alison Evans, Mattia Prosperi, Samantha Lane and Jae Min and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Pharmacology.

In The Last Decade

Vicki Osborne

30 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicki Osborne United Kingdom 10 93 91 85 76 40 34 344
Shl Thomas United Kingdom 11 116 1.2× 61 0.7× 110 1.3× 21 0.3× 24 0.6× 27 617
Joshua Sharfstein United States 10 205 2.2× 53 0.6× 121 1.4× 41 0.5× 28 0.7× 19 459
Shikhar Shrestha United States 13 208 2.2× 243 2.7× 128 1.5× 22 0.3× 28 0.7× 37 501
Einat Gorelik Israel 7 88 0.9× 57 0.6× 55 0.6× 34 0.4× 49 1.2× 8 282
Reema Syed United States 8 46 0.5× 64 0.7× 106 1.2× 23 0.3× 36 0.9× 14 527
Chau Tran Canada 6 56 0.6× 66 0.7× 36 0.4× 15 0.2× 38 0.9× 11 426
Karl E. Williams United States 11 171 1.8× 82 0.9× 104 1.2× 13 0.2× 15 0.4× 19 366
Stuart McTaggart United Kingdom 9 60 0.6× 29 0.3× 72 0.8× 21 0.3× 23 0.6× 21 294
Ada Rubin United States 9 70 0.8× 24 0.3× 67 0.8× 26 0.3× 66 1.6× 9 269
Laura E. Dowsett Canada 12 59 0.6× 31 0.3× 82 1.0× 26 0.3× 143 3.6× 14 404

Countries citing papers authored by Vicki Osborne

Since Specialization
Citations

This map shows the geographic impact of Vicki Osborne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicki Osborne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicki Osborne more than expected).

Fields of papers citing papers by Vicki Osborne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicki Osborne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicki Osborne. The network helps show where Vicki Osborne may publish in the future.

Co-authorship network of co-authors of Vicki Osborne

This figure shows the co-authorship network connecting the top 25 collaborators of Vicki Osborne. A scholar is included among the top collaborators of Vicki Osborne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicki Osborne. Vicki Osborne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Osborne, Vicki, Amie Goodin, Joshua D. Brown, et al.. (2024). Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry. Pharmacoepidemiology and Drug Safety. 33(4). e5789–e5789.
2.
Serdarevic, Mirsada, Vicki Osborne, Catherine W. Striley, & Linda B. Cottler. (2021). Prescription Opioid Use Among a Community Sample of Older and Younger Women. Journal of Women s Health. 31(2). 270–278.
3.
Evans, Alison, et al.. (2021). A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events. Frontiers in Pharmacology. 12. 726141–726141. 6 indexed citations
4.
5.
6.
Osborne, Vicki, et al.. (2020). Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?. BMJ evidence-based medicine. 27(1). 1–6. 27 indexed citations
7.
Osborne, Vicki, et al.. (2020). Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment. Drug Safety. 43(7). 645–656. 43 indexed citations
8.
Osborne, Vicki, et al.. (2020). Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management. BMJ evidence-based medicine. 25(6). 199–205. 7 indexed citations
9.
Jones, Abenaa, Travis Gerke, Catherine W. Striley, et al.. (2019). A Longitudinal Analysis of the Substance Abuse, Violence, and HIV/AIDS (SAVA) Syndemic among Women in the Criminal Justice System. Journal of Psychoactive Drugs. 51(1). 58–67. 10 indexed citations
10.
Jones, Abenaa, Travis Gerke, Catherine W. Striley, et al.. (2017). One Step at a Time: A Latent Transitional Analysis on Changes in Substance Use, Exposure to Violence, and HIV/AIDS Risk Behaviors among Female Offenders. American Journal of Criminal Justice. 43(3). 471–485. 5 indexed citations
11.
12.
Osborne, Vicki & Saad Shakir. (2017). The 9th Biennial Conference on Signal Detection and Interpretation in Pharmacovigilance. Drug Safety. 41(1). 139–141.
13.
Osborne, Vicki, et al.. (2017). Non-medical opioid use in youth: Gender differences in risk factors and prevalence. Addictive Behaviors. 72. 114–119. 49 indexed citations
14.
Osborne, Vicki, et al.. (2016). Utilisation of extended release quetiapine (Seroquel XL™): Results from an observational cohort study in England. European Psychiatry. 33(1). 61–67. 8 indexed citations
15.
16.
Osborne, Vicki, Deborah Layton, & Saad Shakir. (2014). Implications of off-label use: An example from the final results of an observational cohort study on Intrinsa® (testosterone patch). Post Reproductive Health. 20(2). 48–54. 4 indexed citations
17.
Osborne, Vicki, et al.. (2013). Utilization of fentanyl buccal tablets in England: Exploring off‐label use reported in a cohort study. European Journal of Pain. 18(4). 506–512. 7 indexed citations
18.
19.
Osborne, Vicki, Lorna Hazell, Deborah Layton, & Saad Shakir. (2010). Drug Utilization of Intrinsa® (Testosterone Patch) in England. Drug Safety. 33(3). 213–221. 4 indexed citations
20.
Osborne, Vicki, et al.. (2010). Incidence of Venous Thromboembolism in Users of Strontium Ranelate. Drug Safety. 33(7). 579–591. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shl Thomas Breakdown of academic impact, for papers by Joshua Sharfstein Breakdown of academic impact, for papers by Shikhar Shrestha Breakdown of academic impact, for papers by Einat Gorelik Breakdown of academic impact, for papers by Reema Syed Breakdown of academic impact, for papers by Chau Tran Breakdown of academic impact, for papers by Karl E. Williams Breakdown of academic impact, for papers by Stuart McTaggart Breakdown of academic impact, for papers by Ada Rubin Breakdown of academic impact, for papers by Laura E. Dowsett
Rankless by CCL
2026